Skip to Content
Morningstar

Natixis Loomis Sayles Focused Growth ETF LSGR

Morningstar Medalist Rating
Medalist Rating as of | See Natixis Investment Hub

Morningstar’s Analysis LSGR

Will LSGR outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable LSGR’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the LSGR management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of LSGR’s parent organization’s priorities and whether they’re in line with investors’ interests.

Natixis Loomis Sayles Focused Growth ETF’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LSGR

More LSGR Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 66.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

NVIDIA Corp

10.94 15.9 Mil
Technology

Meta Platforms Inc Class A

8.87 12.9 Mil
Communication Services

Amazon.com Inc

8.18 11.9 Mil
Consumer Cyclical

Alphabet Inc Class A

7.59 11.0 Mil
Communication Services

Microsoft Corp

7.45 10.8 Mil
Technology

Tesla Inc

5.23 7.6 Mil
Consumer Cyclical

Netflix Inc

4.88 7.1 Mil
Communication Services

Salesforce Inc

4.63 6.7 Mil
Technology

Autodesk Inc

4.52 6.6 Mil
Technology

Vertex Pharmaceuticals Inc

4.52 6.6 Mil
Healthcare